Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021

Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021

Abstract Background The epidemiology and treatment of acute promyelocytic leukaemia (APL) are changing. We have incorporated oral arsenic trioxide (oral-ATO) into induction/maintenance. Methods Newly-diagnosed APL from 1991 to 2021 divided into three 10-year periods were studied to define its epidem...

Full description

Bibliographic Details
Main Authors: Harinder Gill, Radha Raghupathy, Carmen Y.Y. Lee, Yammy Yung, Hiu-Tung Chu, Michael Y. Ni, Xiao Xiao, Francis P. Flores, Rita Yim, Paul Lee, Lynn Chin, Vivian W.K. Li, Lester Au, Wing-Yan Au, Edmond S.K. Ma, Diwakar Mohan, Cyrus Rustam Kumana, Yok-Lam Kwong
Format: Article
Language:English
Published: BMC 2023-02-01
Series:BMC Cancer
Subjects:
Acute promyelocytic leukaemia
Epidemiology
Oral arsenic trioxide
Early deaths
Survivals
Second primary cancers
Online Access:https://doi.org/10.1186/s12885-023-10612-z

Internet

https://doi.org/10.1186/s12885-023-10612-z

Similar Items